STAT3 and renal cell carcinoma: The ability of FLLL32 and FLLL62 to inhibit STAT3 phosphorylation at Tyr705 was confirmed via immunoblot analysis in a panel of pSTAT3+ human RCC lines (Figure 4D and Figure S4).